219 related articles for article (PubMed ID: 15934048)
1. Engineering substrate specificity of O6-alkylguanine-DNA alkyltransferase for specific protein labeling in living cells.
Juillerat A; Heinis C; Sielaff I; Barnikow J; Jaccard H; Kunz B; Terskikh A; Johnsson K
Chembiochem; 2005 Jul; 6(7):1263-9. PubMed ID: 15934048
[TBL] [Abstract][Full Text] [Related]
2. An engineered protein tag for multiprotein labeling in living cells.
Gautier A; Juillerat A; Heinis C; Corrêa IR; Kindermann M; Beaufils F; Johnsson K
Chem Biol; 2008 Feb; 15(2):128-36. PubMed ID: 18291317
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of bifunctional probes for the specific labeling of fusion proteins.
Kindermann M; Sielaff I; Johnsson K
Bioorg Med Chem Lett; 2004 Jun; 14(11):2725-8. PubMed ID: 15125922
[TBL] [Abstract][Full Text] [Related]
4. Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase.
Kampmeier F; Ribbert M; Nachreiner T; Dembski S; Beaufils F; Brecht A; Barth S
Bioconjug Chem; 2009 May; 20(5):1010-5. PubMed ID: 19388673
[TBL] [Abstract][Full Text] [Related]
5. Specific labeling of O6-alkylguanine-DNA alkyltransferase by reaction with O6-(p-hydroxy[3H]methylbenzyl)guanine.
Ciocco GM; Moschel RC; Chae MY; McLaughlin PJ; Zagon IS; Pegg AE
Cancer Res; 1995 Sep; 55(18):4085-91. PubMed ID: 7664284
[TBL] [Abstract][Full Text] [Related]
6. Protein function microarrays based on self-immobilizing and self-labeling fusion proteins.
Sielaff I; Arnold A; Godin G; Tugulu S; Klok HA; Johnsson K
Chembiochem; 2006 Jan; 7(1):194-202. PubMed ID: 16342318
[TBL] [Abstract][Full Text] [Related]
7. Evolving the substrate specificity of O6-alkylguanine-DNA alkyltransferase through loop insertion for applications in molecular imaging.
Heinis C; Schmitt S; Kindermann M; Godin G; Johnsson K
ACS Chem Biol; 2006 Oct; 1(9):575-84. PubMed ID: 17168553
[TBL] [Abstract][Full Text] [Related]
8. Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling.
Gronemeyer T; Chidley C; Juillerat A; Heinis C; Johnsson K
Protein Eng Des Sel; 2006 Jul; 19(7):309-16. PubMed ID: 16638797
[TBL] [Abstract][Full Text] [Related]
9. [Study of the repair enzyme O6-alkylguanine-DNA-alkyltransferase presence in mammalian cells in vitro].
Lylo VV; Man'ko VH; Nemazanyĭ IO; Kovalenko OO; Matsevych LL; Lukash LL
Tsitol Genet; 2004; 38(6):67-70. PubMed ID: 15882038
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins.
Tirat A; Freuler F; Stettler T; Mayr LM; Leder L
Int J Biol Macromol; 2006 Aug; 39(1-3):66-76. PubMed ID: 16503347
[TBL] [Abstract][Full Text] [Related]
11. Reaction and binding of oligodeoxynucleotides containing analogues of O6-methylguanine with wild-type and mutant human O6-alkylguanine-DNA alkyltransferase.
Spratt TE; Wu JD; Levy DE; Kanugula S; Pegg AE
Biochemistry; 1999 May; 38(21):6801-6. PubMed ID: 10346901
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphorylation is a regulatory mechanism for O6-alkylguanine-DNA alkyltransferase in human brain tumor cells.
Srivenugopal KS; Mullapudi SR; Shou J; Hazra TK; Ali-Osman F
Cancer Res; 2000 Jan; 60(2):282-7. PubMed ID: 10667577
[TBL] [Abstract][Full Text] [Related]
13. Effect of alterations of key active site residues in O6-alkylguanine-DNA Alkyltransferase on its ability to modulate the genotoxicity of 1,2-dibromoethane.
Liu L; Watanabe K; Fang Q; Williams KM; Guengerich FP; Pegg AE
Chem Res Toxicol; 2007 Jan; 20(1):155-63. PubMed ID: 17226938
[TBL] [Abstract][Full Text] [Related]
14. Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide.
Liu L; Xu-Welliver M; Kanugula S; Pegg AE
Cancer Res; 2002 Jun; 62(11):3037-43. PubMed ID: 12036910
[TBL] [Abstract][Full Text] [Related]
15. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
[TBL] [Abstract][Full Text] [Related]
16. Labeling of fusion proteins with synthetic fluorophores in live cells.
Keppler A; Pick H; Arrivoli C; Vogel H; Johnsson K
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):9955-9. PubMed ID: 15226507
[TBL] [Abstract][Full Text] [Related]
17. Function of domains of human O6-alkylguanine-DNA alkyltransferase.
Fang Q; Kanugula S; Pegg AE
Biochemistry; 2005 Nov; 44(46):15396-405. PubMed ID: 16285744
[TBL] [Abstract][Full Text] [Related]
18. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E
J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412
[TBL] [Abstract][Full Text] [Related]
19. Labeling of fusion proteins of O6-alkylguanine-DNA alkyltransferase with small molecules in vivo and in vitro.
Keppler A; Kindermann M; Gendreizig S; Pick H; Vogel H; Johnsson K
Methods; 2004 Apr; 32(4):437-44. PubMed ID: 15003606
[TBL] [Abstract][Full Text] [Related]
20. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
Cai Y; Wu MH; Ludeman SM; Grdina DJ; Dolan ME
Cancer Res; 1999 Jul; 59(13):3059-63. PubMed ID: 10397244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
